GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (OTCPK:CLSH) » Definitions » Degree of Financial Leverage

CLSH (CLS Holdings USA) Degree of Financial Leverage : 0.81 (As of Aug. 2024)


View and export this data going back to 2014. Start your Free Trial

What is CLS Holdings USA Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). CLS Holdings USA's Degree of Financial Leverage for the quarter that ended in Aug. 2024 was 0.81. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for CLS Holdings USA's Degree of Financial Leverage or its related term are showing as below:

CLSH's Degree of Financial Leverage is ranked better than
61.54% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 0.99 vs CLSH: 0.81

CLS Holdings USA Degree of Financial Leverage Historical Data

The historical data trend for CLS Holdings USA's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Degree of Financial Leverage Chart

CLS Holdings USA Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.27 0.71 0.73 -0.28 0.80

CLS Holdings USA Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 1.12 -44.48 0.80 0.81

Competitive Comparison of CLS Holdings USA's Degree of Financial Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Degree of Financial Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Degree of Financial Leverage falls into.



CLS Holdings USA Degree of Financial Leverage Calculation

CLS Holdings USA's Degree of Financial Leverage for the quarter that ended in Aug. 2024 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( -0.05 (Aug. 2024) / -0.18 (Aug. 2023) - 1 )/( -1.05 (Aug. 2024) / -9.438 (Aug. 2023) - 1 )
=-0.7222/-0.8887
=0.81***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


CLS Holdings USA  (OTCPK:CLSH) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


CLS Holdings USA Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Executives
Navy Capital Green Management Llc 10 percent owner, other: See Remark(1) 482 BAYBERRY LANE, MOUNTAINSIDE NJ 07092
Tribeca Investment Partners Pty Ltd 10 percent owner LEVEL 23, 1 O'CONNELL STREET, SYDNEY C3 2000
Ross Silver director 516 SW 13TH STREET, SUITE 201, BEND OR 97702
Andrew Glashow director 1C BOWENS LANDING, NEWPORT RI 02840
David Zelinger director C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Charlene Soco officer: Executive VP of Finance C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Chetan Gulati 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Todd V Swanson 10 percent owner 10120 W. FLAMINGO ROAD, #4333, LAS VEGAS NV 89147
Gregg E. Carlson officer: Chief Financial Officer 2342 MALAGA PEAK STREET, LAS VEGAS NV 89135
Navy Capital Green Co-invest Partners Llc 10 percent owner, other: See Remark(1) 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Co-invest Fund, Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Management Partners Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
John Kaden 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Sean Stiefel 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Fund, Lp 10 percent owner, other: See Remark(2) NAVY CAPITAL GREEN MANAGEMENT, LLC, 28 REICHERT CIRCLE, WESTPORT CT 06880